eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing.
Exozymes stock last closed at $4.31, down 9.26% from the previous day, and has decreased 68.07% in one year. It has underperformed other stocks in the Biotechnology industry by 0.07 percentage points. Exozymes stock is currently +33.02% from its 52-week low of $3.24, and -75.47% from its 52-week high of $17.57.
At the moment, there are 9.28M EXOZ shares outstanding. The market cap of EXOZ is $40.00M. In the past 24 hours, 12,400 EXOZ shares were traded.
You need an online brokerage account to access the NASDAQ market and buy EXOZ stock.
In our opinion, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, the next step is to fill out some personal information so you can invest in EXOZ today.
Now that you have finished signing up on the best stock app for beginners, you can securely and quickly fund your account:
Watch the tutorial below to see the process of depositing funds into your investment account.
Once you have chosen the best place to buy Exozymes stock, it's important to evaluate their stock before you invest, so you can wrap your head around the risk as well as the opportunity.
WallStreetZen was created to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on EXOZ's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge EXOZ's intrinsic value.
Using relative valuations methods:
You can access more valuation research on EXOZ's stock here.
You can dive deeper into what analysts are saying on the Exozymes stock forecast page.
In the past year, executives and large shareholders at EXOZ have bought more shares than they have sold.
Damien Alan Perriman, CCO of EXOZ, was the latest EXOZ insider to sell. They sold $19,428.09 worth of EXOZ stock on Oct 12, 2026.
Learn more about who owns EXOZ stock here.
No, Exozymes doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
There are two main types of orders:
Click the Open Trade button and your broker will execute the order.
If you need more help with buying stocks on eToro, watch the helpful video below:
Now that you own some shares in EXOZ, you'll want to stay up-to-date on your new investment.
Start a watchlist to get notified of the latest news about your EXOZ stock.
To reiterate, here are the 6 steps to buy stock in Exozymes:
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Exozymes, click the button below.